A 36-year-old man was resuscitated after cardiopulmonary arrest due to ventricular fibrillation (VF). He had no family history of sudden cardiac death. Echocardiography did not reveal any cardiac abnormalities. An ECG showed a spontaneous type 1 Brugada (BrS) ECG pattern in leads V1 and V2 (Fig. 1a) . A splice cite variation in SCN5A, c.4810+4G>A, was identified in the genetic analysis. Thus, he was diagnosed with BrS and an implantable cardioverter-defibrillator (ICD) was implanted. During 1 year after implantation of ICD, he received 18 appropriate ICD shocks for VF (Fig. 1b) . After administration of oral quinidine 1200 mg/day and cilostazol 200 mg/day therapy, no appropriate ICD shocks were delivered for 2 years. However, a subsequent episode of a relatively regular ventricular tachycardia (VT), which later converted into fast VT, was documented and successfully terminated by antitachycardia pacing (ATP) (Fig. 1c) .
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One potential mechanism is that drug administration modified the arrhythmogenic substrate and thus facilitated the conversion of malignant VT into a more stable and regular form of VT sensitive to ATP. Although some cases have described VT sensitive to ATP in patients with BrS, the present case is unique in that VT sensitive to ATP was observed 2 years after drug administration in a severely symptomatic BrS patient, who had several appropriate ICD shocks for VF. 
